Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines
Emanuelle Baldo Gaspar, Carlos Roberto Prudêncio, Elizabeth De Gaspari
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 9, pp. 2965-2968
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 82
Vaccine Strategies to Elicit Mucosal Immunity
Yufeng Song, Frances Mehl, Steven L. Zeichner
Vaccines (2024) Vol. 12, Iss. 2, pp. 191-191
Open Access | Times Cited: 24
Bacterial membrane vesicles for vaccine applications
Nishta Krishnan, Luke J. Kubiatowicz, Maya Holay, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114294-114294
Open Access | Times Cited: 70
Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients
A C N Moura, Hernan Hermes Monteiro da Costa, Victor Araujo Correa, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 58
Vaccines, adjuvants and key factors for mucosal immune response
Victor Araujo Correa, Amanda Izeli Portilho, Elizabeth De Gaspari
Immunology (2022) Vol. 167, Iss. 2, pp. 124-138
Open Access | Times Cited: 58
Biological Nanoparticles in Vaccine Development
Stephanie M. Curley, David Putnam
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 45
Outer Membrane Vesicles: An Emerging Vaccine Platform
Dharmendra Kashyap, Mrutyunjaya Panda, Budhadev Baral, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1578-1578
Open Access | Times Cited: 41
Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
Ahmed A. Al‐Karmalawy, Raya Soltane, Ayman Abo Elmaaty, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1317-1317
Open Access | Times Cited: 39
Mucosal vaccines for viral diseases: Status and prospects
Bingjie Ma, Mengxiao Tao, Zhili Li, et al.
Virology (2024) Vol. 593, pp. 110026-110026
Closed Access | Times Cited: 6
Engineered ClearColi™-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate
Leila Sadeghi, Azam Bolhassani, Elham Mohit, et al.
Microbial Pathogenesis (2024) Vol. 193, pp. 106749-106749
Closed Access | Times Cited: 4
Innovative design of bacterial outer membrane vesicles for vaccine development
Qinzhen Cheng, Gaoli Niu, Yiling He, et al.
Nano Today (2025) Vol. 61, pp. 102650-102650
Closed Access
The Two Faces of Bacterial Membrane Vesicles: Pathophysiological Roles and Therapeutic Opportunities
Himadri B. Thapa, Stephan P. Ebenberger, Stefan Schild
Antibiotics (2023) Vol. 12, Iss. 6, pp. 1045-1045
Open Access | Times Cited: 9
Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals
Hernan Hermes Monteiro da Costa, Valéria Oliveira Silva, Gustavo Carvalho Amorim, et al.
Journal of Immunological Methods (2024) Vol. 530, pp. 113683-113683
Closed Access | Times Cited: 3
Hybrid response to SARS-CoV-2 and Neisseria meningitidis C after an OMV-adjuvanted immunization in mice and their offspring
Amanda Izeli Portilho, Hernan Hermes Monteiro da Costa, Marcia Grando Guereschi, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 3
RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2
Hernan Hermes Monteiro da Costa, Diego J. B. Orts, A C N Moura, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 555-555
Open Access | Times Cited: 8
Bacterial Membrane Mimetics: From Biosensing to Disease Prevention and Treatment
Sagar S. Arya, Nada K. Morsy, Deema Islayem, et al.
Biosensors (2023) Vol. 13, Iss. 2, pp. 189-189
Open Access | Times Cited: 7
Recent advances in various bio-applications of bacteria-derived outer membrane vesicles
Leila Sadeghi, Elham Mohit, Samaneh Moallemi, et al.
Microbial Pathogenesis (2023) Vol. 185, pp. 106440-106440
Closed Access | Times Cited: 6
Outer membrane vesicles as versatile tools for therapeutic approaches
Franz G. Zingl, Deborah R. Leitner, Himadri B. Thapa, et al.
microLife (2021) Vol. 2
Open Access | Times Cited: 14
Potential Applications of Microparticulate-Based Bacterial Outer Membrane Vesicles (OMVs) Vaccine Platform for Sexually Transmitted Diseases (STDs): Gonorrhea, Chlamydia, and Syphilis
Christiane Chbib, Sarthak M. Shah, Rikhav P. Gala, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1245-1245
Open Access | Times Cited: 14
Adjuvants to increase immunogenicity of SARS-CoV-2 RBD and support maternal–fetal transference of antibodies in mice
Gabrielle Gimenes Lima, Amanda Izeli Portilho, Elizabeth De Gaspari
Pathogens and Disease (2022) Vol. 80, Iss. 1
Open Access | Times Cited: 7
Bacterial Membrane Vesicles as a Novel Vaccine Platform against SARS-CoV-2
Çiğdem Yılmaz Çolak
Current Microbiology (2024) Vol. 81, Iss. 10
Closed Access | Times Cited: 1
Potential Application of Bionanoparticles to Treat Severe Acute Respiratory Syndrome Coronavirus-2 Infection
Sujit Kumar Debnath, Rohit Srivastava
Frontiers in Nanotechnology (2022) Vol. 3
Open Access | Times Cited: 6
Intranasal and Intramuscular Immunization with Outer Membrane Vesicles from Serogroup C Meningococci Induced Functional Antibodies and Immunologic Memory
Amanda Izeli Portilho, Victor Araujo Correa, Cinthya dos Santos Cirqueira, et al.
Immunological Investigations (2022) Vol. 51, Iss. 7, pp. 2066-2085
Closed Access | Times Cited: 6
Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
Puthupparampil V. Scaria, Christopher G. Rowe, Beth B. Chen, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104739-104739
Open Access | Times Cited: 5
A rational strategy for the maintenance of antiviral immunity to new SARS-CoV-2 strains
Владимир П. Баклаушев, Gaukhar M. Yusubalieva, Mikhail V. Bychinin, et al.
Journal of clinical practice (2022) Vol. 13, Iss. 3, pp. 43-55
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top